SEARCH

SEARCH BY CITATION

References

  • Akkad, A., Oppenheimer, C., Mushambi, M. & Pavord, S. (2003) Intrapartum care for women on full anticoagulation. International Journal of Obstetric Anaesthesia, 12, 188192.
  • Andersen, B.S., Steffensen, F.H., Sørensen, H.T., Nielsen, G.L. & Olsen, J. (1998) The cumulative incidence of venous thromboembolism during pregnancy and puerperium – an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstetricia et Gynecologica Scandinavica, 77, 170173.
  • Baglin, T. (2003) Management of thrombophilia: who to screen? Pathophysiology of Haemostasis and Thrombosis, 33, 401404.
  • Barbour, L.A., Oja, J.L. & Schultz, L.K. (2004) A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. American Journal of Obstetrics & Gynecology, 191, 10241029.
  • Blanco-Molina, M.A., Trujillo, S.J., Criado, J., Lopez, L., Lecumberri, R., Gutierrez, R., Monreal, M. & Investigators, R. (2007) Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thrombosis & Haemostasis, 97, 186190.
  • Blomback, M., Bremme, K., Helligan, M., Siegbahn, A. & Lindberg, H. (1998) Thromboprophylaxis with low molecular mass heparin, Fragmin (dalteparin), during pregnancy – a longitudinal safety study. Blood Coagulation & Fibrinolysis, 9, 19.
  • Brill-Edwards, P., Ginsberg, J.S., Gent, M., Hirsh, J., Burrows, R., Kearon, C., Geerts, W., Kovacs, M., Weitz, J.I., Robinson, K.S., Whittom, R. & Couture, G. &Recurrence of Clot in This Pregnancy Study Group (2000) Safety of withholding heparin in pregnant women with a history of venous thromboembolism Recurrence of Clot in This Pregnancy Study Group. New England Journal of Medicine, 343, 14391444.
  • Brocklehurst, P. & Gates, S. (2002) Randomized controlled trial (PEACH) and meta-analysis of thromboprophylaxis using low molecular weight heparin (enoxaparin) after caesarean section. Journal of Obstetrics & Gynaecology, 22, S52.
  • Buller, H.R., Sohne, M. & Middeldorp, S. (2005) Treatment of venous thromboembolism. Journal of Thrombosis & Haemostasis, 3, 15541560.
  • Casele, H.L., Laifer, S.A., Woelkers, D.A. & Venkataramanan, R. (1999) Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. American Journal Obstetrics & Gynecology, 181, 11131117.
  • CEMACH (2004) Why Mothers Die 2000–2002. The Sixth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. RCOG Press, London.
  • Combs, C.A., Murphy, E.L. & Laros, R.K., Jr (1991) Factors associated with postpartum hemorrhage with vaginal birth. Obstetrics and Gynecology, 77, 6976.
  • Cosmi, B., Legnani, C., Bernardi, F., Coccheri, S. & Palareti, G. (2003) Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception. Archives of Internal Medicine, 163, 11051109.
  • Ellison, J., Walker, I.D. & Greer, I.A. (2000) Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy. British Journal of Obstetrics & Gynaecology, 107, 11161121.
  • Gates, S., Brocklehurst, P. & Davis, L.J. (2002) Antenatal thromboprophylaxis using low molecular weight heparin (enoxaparin) for women at risk of thrombembolic disease: multicentre placebo controlled randomized trial (APPLE) and systematic review. Journal Obstetrics & Gynaecology, 22, S44.
  • Gates, S., Brocklehurst, P., Campbell, M. & Elbourne, D. (2004a) Recruitment to multicentre trials. BJOG: International Journal of Obstetrics and Gynaecology, 111, 35.
  • Gates, S., Brocklehurst, P., Ayers, S. & Bowler, U. &Thromboprophylaxis in Pregnancy Advisory Group(2004b) Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin. American Journal of Obstetrics & Gynecology, 191, 12961303.
  • Gerhardt, A., Scharf, R.E., Beckmann, M.W., Struve, S., Bender, H.G., Pillny, M., Sandmann, W. & Zotz, R.B. (2000) Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. New England Journal of Medicinie, 342, 374380.
  • Ginsberg, J.S., Brill-Edwards, P., Burrows, R.F., Bona, R., Prandoni, P., Büller, H.R. & Lensing, A. (1992) Venous thrombosis during pregnancy: leg and trimester of presentation. Thrombosis & Haemostasis, 67, 519520.
  • Greer, I.A. & Nelson-Piercy, C. (2005) Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood, 106, 401407.
  • Heit, J.A., Kobbervig, C.E., James, A.H., Petterson, T.M., Bailey, K.R. & Melton, L.J. III (2005) Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Annals of Internal Medicine, 143, 697706.
  • Hunt, B.J., Doughty, H.A., Majumdar, G., Copplestone, A., Kerslake, S., Buchanana, N., Hughes, G. & Khamashta, M. (1997) Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thrombosis & Haemostasis, 77, 3943.
  • Jacobsen, A.F., Qvigstad, E. & Sandset, P.M. (2003) Low molecular weight heparin dalteparin for the treatment of venous thromboembolism in pregnancy. BJOG: An International Journal of Obstetrics and Gynaecology, 110, 139144.
  • Jorgensen, M. & Nielsen, J.D. (2004) The low molecular weight heparin, tinzaparin, is effective and safe in the treatment and prophylaxis of venous thromboembolic disease during pregnancy. Blood, 104, 1774S.
  • Kahn, S.R. & Ginsberg, J.S. (2002) The post-thrombotic syndrome: current knowledge, controversies and directions for future research. Blood Reviews, 16, 15565.
  • Kher, A., Bauersachs, R. & Nielsen, J.D. (2007) The management of thrombosis in pregnancy: Role of low-molecular-weight heparin. Thrombosis & Haemostasis, 97, 505513.
  • Kitchen, S. (2000) Problems in laboratory monitoring of heparin dosage. British Journal of Haematololgy, 111, 397406.
  • Knight, M., Kurinczuk, J., Tuffnell, D. & Brocklehurst, P. (2005) The UK Obstetric Surveillance System for rare disorders of pregnancy. BJOG: An International Journal of Obstetrics and Gynaecology, 112, 263265.
  • Kominiarek, M.A., Angelopoulos, S.M., Shapiro, N.L., Studee, L., Nutescu, E.A. & Hibbard, J.U. (2007) Low-molecular-weight heparin in pregnancy: peripartum bleeding complications. Journal of Perinatology : Official Journal of the California Perinatal Association, 27, 329334.
  • Larsen, T.B., Sørensen, H.T., Gislum, M. & Johnsen, S.P. (2007) Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case–control study. Thrombosis Research 120, 505509.
  • Lepercq, J., Conard, J., Borel, D.A., Darmon, J.Y., Boudignat, O., Francoual, C., Priollet, P., Cohen, C., Yvelin, N., Schved, J.F., Tournaire, M. & Borg, J.Y. (2001) Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG: An International Journal of Obstetrics and Gynaecology, 108, 11341140.
  • Lindhagen, A., Bergqvist, A., Bergqvist, D. & Hallbook, T.. (1986) Late venous function in the leg after deep venous thrombosis occurring in relation to pregnancy. British Journal of Obstetrics & Gynaecology, 93, 348352.
  • Lindqvist, P., Dahlbäck, B. & Marsál, K. (1999) Thrombotic risk during pregnancy: a population study. Obstetrics and Gynecology, 94, 595599.
  • Macklon, N.S. & Greer, I.A. (1996) Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scottish Medical Journal, 41, 8386.
  • Magann, E.F., Evans, S., Hutchinson, M., Collins, R., Howard, B.C. & Morrison, J.C. (2005) Postpartum hemorrhage after vaginal birth: an analysis of risk factors. Southern Medical Journal, 98, 419422.
  • McColl, M.D., Ramsay, J.E., Tait, R.C., Walker, I.D., McCall, F., Conkie, J.A., Carty, M.J. & Greer, I.A. (1997) Risk factors for pregnancy associated venous thromboembolism. Thrombosis & Haemostasis, 78, 11831188.
  • McColl, M.D., Ellison, J., Reid, F., Tait, R.C., Walker, I.D. & Greer, I.A. (2000) Prothrombin 20210 G[RIGHTWARDS ARROW]A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. BJOG: An International Journal of Obstetrics and Gynaecology, 107, 565569.
  • Nenci, G.G. (2003) Low molecular weight heparins: are they interchangeable? NO. Journal of Thrombosis & Haemostasis: JTH, 1, 1213.
  • Nijkeuter, M., Ginsberg, J.S. & Huisman, M.V. (2006) Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review. Journal of Thrombosis & Haemostasis, 4, 496500.
  • Norris, L.A., Bonnar, J., Smith, M.P., Steer, P.J. & Savidge, G. (2004) Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacological study. Thrombosis & Haemostasis, 92, 7916.
  • O’Connell, M.P., O’Leary, M., MacKeogh, L., Murphy, K. & Keane, D.P. (2004) Is the monitoring of anti-Xa activity necessary in pregnant women undergoing thromboprophylaxis? European Journal of Obstetrics & Gynecology, 114, 1214.
  • Pabinger, I., Grafenhofer, H., Kyrle, P.A., Quehenberger, P., Mannhalter, C., Lechner, K. & Kaider, A. (2002) Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood, 100, 10601062.
  • Pabinger, I., Grafenhofer, H., Kaider, A., Kyrle, P.A., Quehenberger, P., Mannhalter, C. & Lechner, K. (2005) Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. Journal of Thrombosis and Haemostasis: JTH, 3, 949954.
  • Parker, M.S., Hui, F.K., Camacho, M.A., Chung, J.K., Broga, D.W. & Sethi, N.N. (2005) Female breast radiation exposure during CT pulmonary angiography. American Journal of Roentgenology, 185, 12281233.
  • Prandoni, P. (2003) Low molecular weight heparins: are they interchangeable? Yes. Journal of Thrombosis and Haemostasis: JTH, 1, 1011.
  • Prandoni, P., Lensing, A.W.A. & Pesavento, R. (2006) New strategies for the treatment of acute venous thromboembolism. Seminars in Thrombosis and Hemostasis, 32, 787792.
  • Ray, J.G. & Chan, W.S. (1999) Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstetrical & Gynecological Survey, 54, 265271.
  • RCOG(2004) Thromboprophylaxis during Pregnancy, Labour & After Vaginal Delivery. Guideline no.37. Royal College of Obstetricians and Gynaecologists Press,London. Available at: http://www.rcog.org.uk/resources/Public/pdf/Thromboprophylaxis_no037.pdf (accessed on 31 August 2007).
  • RCOG(2007) Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management. RCOG Green-top Guideline No.28 Second Edition.Royal College of Obstetricians and Gynaecologists Press, London. Available at: http://www.rcog.org.uk/resources/Public/pdf/green_top_28_thromboembolic_minorrevision.pdf (accessed on 31 August 2007).
  • Rey, E. & Rivard, G.E. (2000) Prophylaxis and treatment of thromboembolic diseases during pregnancy with dalteparin. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics, 71, 1924.
  • Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G.D.O., Walker, I.D., Greaves, M., Brenkel, I., Regan, L. & Greer, I.A. & The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening, S. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132, 171196.
  • Rodie, V.A., Thomson, A.J., Stewart, F.M., Quinn, A.J., Walker, I.D. & Greer, I.A. (2002) Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series. BJOG : An International Journal of Obstetrics and Gynaecology, 109, 10201024.
  • Rosfors, S., Norén, A., Hjertberg, R., Persson, L., Lillthors, K. & Törngren, S. (2001) A 16-year haemodynamic follow-up of women with pregnancy-related medically treated iliofemoral deep venous thrombosis. European Journal of Vascular and Endovascular Surgery: the Official Journal of The European Society For Vascular Surgery, 22, 448455.
  • Rowan, J.A., McLintock, C., Taylor, R.S. & North, R.A. (2003) Prophylactic and therapeutic enoxaparin during pregnancy: indications, outcomes and monitoring. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 43, 123128.
  • Samama, M.M., Rached, R.A., Horellou, M.H., Aquilanti, S., Mathieux, V.G., Plu, B.G., Elalamy, I. & Conard, J. (2003) Pregnancy-associated venous thromboembolism VTE in combined heterozygous factor V Leiden FVL and prothrombin FII 20210 A mutation and in heterozygous FII single gene mutation alone. British Journal of Haematology, 123, 327334.
  • Sephton, V., Farquharson, R.G., Topping, J., Quenby, S.M., Cowan, C., Back, D.J. & Toh, C.H. (2003) A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy. Obstetrics & Gynecology, 101, 13071311.
  • Simpson, E.L., Lawrenson, R.A., Nightingale, A.L. & Farmer, R.D. (2001) Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG : An International Journal of Obstetrics and Gynaecology, 108, 5660.
  • Smith, M.P., Norris, L.A., Steer, P.J., Savidge, G.F. & Bonnar, J. (2004) Tinzaparin sodium for thrombosis treatment and prevention during pregnancy. American Journal of Obstetrics & Gynecology, 190, 495501.
  • Stones, R.W., Paterson, C.M. & Saunders, N.J. (1993) Risk factors for major obstetric haemorrhage. European Journal of Obsterics Gynecology and Reproductive Biology, 48, 1518.
  • Ulander, V.M., Stenqvist, P. & Kaaja, R. (2002) Treatment of deep venous thrombosis with low-molecular-weight heparin during pregnancy. Thrombosis Research, 106, 1317.
  • Walker, I.D., Greaves, M. & Preston, F.E. (2001) Investigation and management of heritable thrombophilia. British Journal of Haematology, 114, 512528.
  • White, R.H. & Ginsberg, J.S. (2003) Low molecular weight heparins: are they all the same? British Journal of Haematology, 121, 1220.
  • Wysowski, D.K., Talarico, L., Bacsanyi, J. & Botstein, P. (1998) Spinal and epidural hematoma and low-molecular-weight heparin. The New England Journal of Medicine, 338, 17741775.